Cohen–Gibson syndrome

From WikiMD's Medical Encyclopedia

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Cohen–Gibson syndrome
Synonyms
Pronounce
Specialty Medical genetics
Symptoms Overgrowth, developmental delay, intellectual disability, distinctive facial features
Complications N/A
Onset
Duration
Types
Causes Mutations in the EED gene
Risks
Diagnosis Genetic testing, clinical evaluation
Differential diagnosis
Prevention
Treatment Supportive care, symptomatic treatment
Medication
Prognosis
Frequency Rare
Deaths


A rare genetic disorder


Cohen–Gibson syndrome is a rare genetic disorder characterized by distinctive facial features, developmental delay, and skeletal abnormalities. It is caused by mutations in the EED gene, which plays a crucial role in the regulation of gene expression.

Genetics[edit]

Cohen–Gibson syndrome is inherited in an autosomal dominant manner. This means that a single copy of the altered gene in each cell is sufficient to cause the disorder. The EED gene is part of the Polycomb repressive complex 2 (PRC2), which is involved in the modification of chromatin and regulation of gene expression.

Clinical Features[edit]

Individuals with Cohen–Gibson syndrome typically present with a range of clinical features, including:

  • Distinctive facial features: These may include a broad forehead, wide-set eyes, and a small chin.
  • Developmental delay: Affected individuals often experience delays in reaching developmental milestones such as sitting, walking, and talking.
  • Skeletal abnormalities: These can include short stature, joint hypermobility, and other bone-related issues.
  • Other features: Some individuals may have congenital heart defects, hearing loss, or vision problems.

Diagnosis[edit]

The diagnosis of Cohen–Gibson syndrome is based on clinical evaluation and genetic testing. Genetic testing can confirm the presence of mutations in the EED gene.

Management[edit]

Management of Cohen–Gibson syndrome is symptomatic and supportive. It may involve a multidisciplinary team of specialists, including pediatricians, geneticists, orthopedists, and speech therapists. Early intervention programs can help address developmental delays.

Prognosis[edit]

The prognosis for individuals with Cohen–Gibson syndrome varies depending on the severity of symptoms and the presence of associated health issues. With appropriate management, many individuals can lead fulfilling lives.

See also[edit]

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?

Get started with evidence based, physician-supervised

affordable GLP-1 weight loss injections

Now available in New York City and Philadelphia:

✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends

Learn more:

Start your transformation today with W8MD weight loss centers.

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.